AUSTER MARTIN (Chief Financial Officer) sold 37.0% of their position (28K shares) of VENTYX BIOSCIENCES, INC. on the open market
Open‑market sale worth $1.06M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 4/27/2023ACC: 0001209191-23-025876
Officer· Chief Financial Officer
Since Oct 2021
-28K
Net shares
Net seller
$1.06M
Total sold
3
Open market trades
0B · 3S
5
Total transactions
28K acquired · 56K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+28K
Price / share
$3.45
Trade value
$96.60K
% of position
58.8%
4/25/2023
47.65K→75.65K
Common Stock
Direct
Shares
−18.75K
Price / share
$37.55
Trade value
$704.06K
% of position
24.8%
4/25/2023
75.65K→56.90K
Common Stock
Direct
Shares
−4.26K
Price / share
$38.76
Trade value
$165.18K
% of position
7.5%
4/25/2023
56.90K→52.64K
Common Stock
Direct
Shares
−4.99K
Price / share
$39.23
Trade value
$195.75K
% of position
9.5%
4/25/2023
52.64K→47.65K
Total
Net shares
+0.00
Net value
-$968.39K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/25/2023 | M · Option Exercise | +28K | $3.45 | $96.60K | 58.8% | 47.65K | 75.65K |
| Common Stock Direct | 4/25/2023 | S · Sale | −18.75K | $37.55 | $704.06K | 24.8% | 75.65K | 56.90K |
| Common Stock Direct | 4/25/2023 | S · Sale | −4.26K | $38.76 | $165.18K | 7.5% | 56.90K | 52.64K |
| Common Stock Direct | 4/25/2023 | S · Sale | −4.99K | $39.23 | $195.75K | 9.5% | 52.64K | 47.65K |
| Total | +0.00 | -$968.39K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
28K shares
Shares
−28K
Strike price
3.45
Held after
275.18K
Exercisable
—
4/25/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock28K shares | 4/25/2023 | M · Option Exercise | −28K | 3.45 | — | 275.18K |